Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed5

Role Distribution

Other Roles5

Activity Timeline

Clinical Trials (5)

NCT05249257Completed
Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity
CelluliteEdematous Fibrosclerotic PanniculopathyLaxity; Skin
StudydirectorStart date: 2022-01-25
NCT04381117Completed
Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)
Edematous Fibrosclerotic Panniculopathy
StudydirectorStart date: 2020-05-06
NCT04236635Phase 2Completed
Histopathology Following CCH Injection
Characteristics of Subcutaneous Tissue
StudydirectorStart date: 2019-12-20
NCT03893890Completed
Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women
Edematous Fibrosclerotic Panniculopathy
StudydirectorStart date: 2019-03-28
NCT03526549Phase 3Completed
Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)
CelluliteEdematous Fibrosclerotic Panniculopathy
StudydirectorStart date: 2018-04-26

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Endo USA Inc., a Keenova Therapeutics Company

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Hernandez

Endo USA Inc., a Keenova Therapeutics Company

Related
4 trials

Shared therapeutic areas:

CelluliteEdematous Fibrosclerotic PanniculopathyLaxity; Skin

Worked with same sponsors:

Endo USA Inc., a Keenova Therapeutics Company
Similarity Score23%

Mike McLane

Endo USA Inc., a Keenova Therapeutics Company

Related
1 trials

Shared therapeutic areas:

CelluliteEdematous Fibrosclerotic Panniculopathy

Worked with same sponsors:

Endo USA Inc., a Keenova Therapeutics Company
Similarity Score15%

Mike McLane, PhD

Endo USA Inc., a Keenova Therapeutics Company

Related
1 trials

Shared therapeutic areas:

CelluliteEdematous Fibrosclerotic Panniculopathy

Worked with same sponsors:

Endo USA Inc., a Keenova Therapeutics Company
Similarity Score15%

Veronica Urdaneta, MD MPH

Endo USA Inc., a Keenova Therapeutics Company

Related
3 trials

Shared therapeutic areas:

CelluliteEdematous Fibrosclerotic Panniculopathy

Worked with same sponsors:

Endo USA Inc., a Keenova Therapeutics Company
Similarity Score15%

Patricia Krantz

Cytrellis Biosystems, Inc.

Related
1 trials

Shared therapeutic areas:

Laxity; Skin
Similarity Score8%

David Goldberg, MD

Skin Laser & Surgery Specialist of NY/NJ

Related
1 trials

Shared therapeutic areas:

Cellulite
Similarity Score8%

Girish Munavalli, MD

Laser & Vein Specialists of the Carolinas, 1918 Randolph Road, Suite 550, Charlotte, NC 28270

Related
1 trials

Shared therapeutic areas:

Cellulite
Similarity Score8%

Doris Hexsel, MD

Hexsel Dermatology Clinic

Related
1 trials

Shared therapeutic areas:

Cellulite
Similarity Score8%

Woraphong Manuskiatti, MD

Mahidol University

Related
3 trials

Shared therapeutic areas:

Laxity; Skin
Similarity Score8%

Murad Alam, MD

Northwestern University

Related
65 trials

Shared therapeutic areas:

Cellulite
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05249257StudyDirector

Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity

CelluliteEdematous Fibrosclerotic PanniculopathyLaxity; Skin
Completed
NCT04381117StudyDirector

Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)

Edematous Fibrosclerotic Panniculopathy
Completed
NCT04236635Phase 2StudyDirector

Histopathology Following CCH Injection

Characteristics of Subcutaneous Tissue
Completed
NCT03893890StudyDirector

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Edematous Fibrosclerotic Panniculopathy
Completed
NCT03526549Phase 3StudyDirector

Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)

CelluliteEdematous Fibrosclerotic Panniculopathy
Completed

All 5 trials loaded